Back to Top Skip to main content Skip to sub-navigation

Patients Contribute to Shape Future Hearing Loss Treatment

Barbara Kelly from the Hearing Loss Association of America hosting a meeting Barbara Kelley, executive director of the Hearing Loss Association of America (left), kicks off the first-ever externally led patient-focused drug development meeting for hearing loss May 25, which heard from patients living with hearing loss, to aid in the Food and Drug Administration’s development of future hearing loss therapies. The Defense Health Agency’s Hearing Center of Excellence was among key collaborators involved in the event (Courtesy of HLAA).

Recommended Content:

Centers of Excellence | Vision and Hearing Loss Prevention | Hearing and Balance Injuries | Vision and Hearing Loss Prevention

The Defense Health Agency's Hearing Center of Excellence collaborated in a first-of-its-kind effort to aid in the development of future drug therapies and devices for patients with hearing loss. During the meeting authorized by the Food and Drug Administration, patients with hearing loss shared their testimonies.

The Hearing Loss Association of America (HLAA) hosted the externally led, patient-focused, drug development meeting for people living with sensorineural (inner ear damage) hearing loss May 25, with key FDA reviewers in attendance. The FDA establishes these types of meetings to help inform its decisions and supervision during drug development and review of marketing applications.

"This was an important opportunity for patients to tell the FDA about their symptoms, assessment of current treatments, experiences, and challenges they face living with hearing loss as a way to personally address their needs and conditions," said the HCE's division chief, Dr. Carlos Esquivel. "We were honored to collaborate as a patient organization with a dedicated interest in improving care and medications for those with hearing loss."

During the meeting, Dr. Gavin Imperato, with the FDA's Office of Tissues and Advanced Therapies, expressed enthusiasm at the opportunity to hear from patients as the FDA considers specific therapies for people with hearing loss.

The event included two panels of people with hearing loss and a group of patients, caregivers, and their families joining remotely, who shared their most burdensome symptoms, current treatments, and what they would like to see in future therapies.

According to the HLAA, the report Voice of the Patient will be published in the fall based on information from the meeting and comments from patients submitted to the organization through June 25.

The HCE's collaboration in the virtual meeting is a continuation of the center's ongoing engagement with the HLAA on several initiatives, dating back to 2014, according to Esquivel.

In other related efforts, HCE is leading the Pharmaceutical Interventions for Hearing Loss Working Group, which is examining drug development initiatives for service member and veteran hearing loss. The center also provides subject matter expert support to the Department of Defense's acquisition of the Pharmaceutical Intervention for Noise-induced Hearing Loss initiative.

You also may be interested in...

Acute Concussion Pathway of Care: MACE 2 and PRA Training

Publication
10/26/2021

The Traumatic Brain Injury Center of Excellence is hosting a combined Military Acute Concussion Evaluation (MACE 2) and Progressive Return to Activity (PRA) clinical recommendation virtual training.

Recommended Content:

Traumatic Brain Injury Center of Excellence | Provider Resources | TBI Education and Training Events | TBI Educators | Centers of Excellence

Assessment and Management of Dizziness and Visual Disturbances Following Concussion/Mild Traumatic Brain Injury

Publication
10/22/2021

This clinical recommendation provides medical staff with a single, comprehensive reference for the assessment and management of dizziness and visual disturbances following mild TBI/concussion. Dizziness and visual disturbances often present with overlapping symptoms and should prompt a provider to perform a visual and dizziness—or vestibular—assessment.

Recommended Content:

Traumatic Brain Injury Center of Excellence | Provider Resources | TBI Resources | Centers of Excellence

Improving Relationships after TBI

Publication
10/21/2021

Flier for the Interactive Relationship Building Workshop for Active-Duty Military and Veteran TBI Caregivers and Families: This flier provides information on TBICoE's educational session for caregivers of active-duty service members and veterans who have sustained a TBI. In addition to sharing caregiver resources and current research initiatives, webinar topics will also include relationship building strategies, improving communication and addressing intimacy after TBI.

Recommended Content:

Traumatic Brain Injury Center of Excellence | Patient and Family Resources | Provider Resources | Centers of Excellence | TBI Resources

2000-Q2 2021 DOD Worldwide Numbers for TBI

Publication
10/14/2021

TBICoE is the Defense Department’s office of responsibility for tracking traumatic brain injury data in the U.S. military. Here you’ll find data on the number of active-duty service members—anywhere U.S. forces are located—with a first-time TBI diagnosis from calendar year 2000 through the second quarter of 2021. The data is also broken down by each branch of the armed services.

Recommended Content:

Traumatic Brain Injury Center of Excellence | DOD TBI Worldwide Numbers | Centers of Excellence | Traumatic Brain Injury

NICoE Education Webinar Series: July Poster

Publication
6/25/2021

Service Members and TBI: The Not So Invisible Wound

Recommended Content:

Traumatic Brain Injury | TBI Education and Training Events | Centers of Excellence
Showing results 1 - 5 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.